Xiao Bing Li

Xiao Bing Li

Corporate Officer/Principal chez CLOVER BIOPHARMACEUTICALS, LTD.
58 ans
Health Technology
Consumer Services

Profil

Xiao Bing Li is currently the Executive Vice President at Clover Biopharmaceuticals Ltd. Prior to this, he held positions as Senior Director at Ironwood Pharmaceuticals, Director at Janssen Pharmaceuticals, Director at Alkermes Plc, and Senior Director at SAGE Therapeutics.
He also served as Vice President-Program Management at Voyager Therapeutics.
Dr. Li holds a doctorate from Princeton University, an MBA from Colorado State University, and an undergraduate degree from Nankai University.

Postes actifs de Xiao Bing Li

SociétésPosteDébut
CLOVER BIOPHARMACEUTICALS, LTD. Corporate Officer/Principal 27/07/2020

Anciens postes connus de Xiao Bing Li

SociétésPosteFin
SAGE THERAPEUTICS, INC. Directeur/Membre du Conseil 01/05/2018
IRONWOOD PHARMACEUTICALS, INC. Directeur/Membre du Conseil 01/03/2016
ALKERMES PLC Directeur/Membre du Conseil 01/07/2014
Directeur/Membre du Conseil 01/09/2010
VOYAGER THERAPEUTICS, INC. Corporate Officer/Principal -
Voir l'expérience en détail de Xiao Bing Li

Formation de Xiao Bing Li

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

91

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Xiao Bing Li